PROMIS-AD
Study Title: Protocol for Maintaining and Improving Mental Status in Alzheimer’s Disease (PROMIS-AD) - a Pilot Study of Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer's Disease
Purpose
In this clinical trial, we are testing the effectiveness of repetitive Transcranial Magnetic Stimulation (TMS) on the treatment of Alzheimer’s Disease. We welcome English-speaking individuals age 60 to 100 years old with an Alzheimer’s diagnosis or probable Alzheimer’s to enroll. Participants will receive either active or sham TMS, and those who receive sham stimulation may be eligible to receive open-label active treatment after the completion of the study. Participation in the study would last up to 5 weeks for those receiving active stimulation and up to 10 weeks for those receiving sham.
(PI: Michael Leuchter, MD)
Contact: Cole Matthews at tmsresearch@mednet.ucla.edu or call (310) 825-4781 to participate or for more information.
More information on the PROMIS-AD study is available at clinicaltrials.gov ID#: NCT06597942.